A Rare Complication of Campylobacter Sepsis in an Infant

Abstract

Get full access to this article

View all access options for this article.

References

Morag

Epelman

Daneman

et al . Portal vein thrombosis in the neonate: risk factors, course, and outcome. J Pediatr. 2006;148:735-739.

Rehan

Cronin

Bowman

. Neonatal portal vein thrombosis successfully treated by regional streptokinase infusion. Eur J Pediatr. 1994;153:456-459.

Wilson

Robinson

Hacking

. Portal hypertension in childhood. Br J Surg. 1969;56:13-22.

Revel-Vilk

Chan

Bauman

Massicotte

. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost.2003;1:915-921.

Sakha

Rafeey

Tarzamani

. Portal venous thrombosis after umbilical vein catheterization. Indian J Gastroenterol. 2007;26:283-284.

Alvarez

Bernard

Brunelle

Hadchouel

Odievre

Alagille

. Portal obstruction in children. I Clinical investigation and hemorrhage risk. J Pediatr. 1983;103:696-702.

Lykavieris

Gauthier

Hadchouel

Duche

Bernard

. Risk of gastrointestinal bleeding during adolescence and early adulthood in children with portal vein obstruction. J Pediatr. 2000;136:805-808.

Williams

Chan

. Neonatal portal vein thrombosis: diagnosis and management. Semin Fetal Neonatal Med. 2011;16:329-339.

Jensen

Campbell

Alonso

Nathan

Ryckman

Tiao

. Management and long-term consequences of portal vein thrombosis after liver transplantation in children. Liver Transpl. 2013;19:315-321.

10.

Licinio

Principi

Losurdo

Castellaneta

Ierardi

Di Leo

. Low molecular weight heparin in portal vein thrombosis of cirrhotic patients: only therapeutic purposes? ScientificWorldJournal. 2014;2014:895839. doi:10.1155/2014/895839.

11.

Schmidt

Ofosu

Mitchell

Brooker

Andrew

. Anticoagulant effects of heparin in neonatal plasma. Pediatr Res. 1989;25:405-408.

12.

Guyatt

Akl

Crowther

Gutterman

Schuünemann

; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis., 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):7S-47S.

13.

Michelson

Bovill

Monagle

Andrew

. Antithrombotic therapy in children. Chest. 1998;114(5 suppl):748S-769S.

14.

Malowany

Monagle

Knoppert

et al ; Canadian Paediatric Thombosis and Hemstasis Network. Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates. Thromb Res. 2008;122:826-830.

15.

Warkentin

Levine

Hirsh

et al . Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332:1330-1335.

16.

Rocha

Martinez-Gonzalez

Montes

Panizo

. Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis. Haematologica. 2000;85:935-942.

17.

Dix

Andrew

Marzinotto

et al . The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr. 2000;136:439-445.